
Top Stories 
Published On June 1, 2005
CLINICAL RESEARCH
Engineering Better Treatments
A cross disciplinary approach has begun to pay dividends for endometriosis research.
Linda Griffith was trained as a chemical engineer and became a pioneer in the sub-specialty of tissue engineering, a research field that re-creates biologic forms by using both man-made materials and living cells. These days, as scientific director of the MIT Center for Gynepathology Research, Griffith not only leads research but also serves as a kind of institutional cheerleader, inspiring scientists across many disciplines to join the center’s work to address endometriosis and other women’s reproductive disorders.
Among the recruits to that quest is tissue engineering itself. Griffith also directs one of the national programs that aims to create a “human physiome on a chip.” This effort to create a microscale model of 10 interlocked human physiological systems, incorporating human cells, would be a boon to medical researchers. Scientists would be able to use it to study biological processes, learn what goes wrong in various diseases, and test drugs in preparation for animal and human testing.
Griffith made sure that a woman’s reproductive system would be included in that effort, in the form of a model endometrium. She is also working on sex-specific culture mediums to investigate the differences in male and female responses to drugs. In creating such models, she and other researchers are hoping that drugmakers may get involved in research on endometriosis and related maladies that have long shown few possibilities for effective treatments.
Dispatches

What Makes a Kid Clumsy? More research into coordination disorders shows why some children are more prone to trip, fumble and spill the milk.

Eyes in the Sky Satellite data can be used to assess the health impact of dust storms and the spread of mosquito-borne diseases. Additional applications could be on the horizon.

Could This One Change Help Curb the Opioid Crisis? To prescribe an effective bridge to addiction treatment, emergency physicians must get special training and receive a waiver. Making that process easier—or eliminating the requirement altogether—could make a big impact.

One Thing Leads to the Next Robert Lefkowitz is best known for revealing the mechanism behind hundreds of drugs in use today. But he thinks of himself as a storyteller first and has a new book out to make his case.

Podcast: The Research Year That Was Medical research labs have faced a difficult stretch of closed buildings and competing priorities. Yet they have also produced milestone discoveries—and not only on COVID-19.

The Shape of Us Two milestone discoveries in protein modeling promise to change the fundamentals of drug discovery.

Universal Flu Vaccines Move Forward In the shadow of coronavirus vaccine development, another vaccine was making solid progress.

Top Stories 

The Neuroscience of Giving Up
Why do some people react poorly, even catastrophically, in emergency situations?